Inventor · disambiguated record
Peter Petzelbauer
Also filed as: PETZELBAUER PETER
11 granted patents·10 pending applications·48 citations·filing 1994–2011
86Inventor score
Files withFIBREX MEDICAL RES & DEV GMBH9IKARIA DEV SUBSIDIARY TWO LLC4PETZELBAUER PETER4FIBREX MEDICAL RES & DEV GESMB1FUMAPHARM AG1
Top patents by PatentIndex Score
21 records- 0183US8088890B2Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical compositionPETZELBAUER PETER·Filed 2008·Granted Jan 3, 2012·8 cites·10 claims
- 0278US7884074B2Compounds and methods for prevention and/or treatment of inflammation using the sameIKARIA DEV SUBSIDIARY TWO LLC·Filed 2008·Granted Feb 8, 2011·8 cites·10 claims
- 0378US7271144B2Therapeutic fibrin-derived peptides and uses thereofFIBREX MEDICAL RES & DEV GMBH·Filed 2003·Granted Sep 18, 2007·13 cites·4 claims
- 0477US7494973B2Therapeutic fibrin-derived peptides and uses thereofFIBREX MEDICAL RES & DEV GMBH·Filed 2006·Granted Feb 24, 2009·3 cites·3 claims
- 0563US8067373B2Therapeutic fibrin-derived peptides and uses thereofPETZELBAUER PETER·Filed 2008·Granted Nov 29, 2011·0 cites·6 claims
- 0659US7811985B2Therapeutic fibrin-derived peptides and uses thereofIKARIA DEV SUBSIDIARY TWO LLC·Filed 2007·Granted Oct 12, 2010·0 cites·5 claims
- 0756US2010113740A1Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical compositionFIBREX MEDICAL RES & DEV GMBH·Filed 2009·Application pending·0 cites
- 0855US7799758B2Peptides and peptide derivatives as well as pharmaceutical compositions containing the sameIKARIA DEV SUBSIDIARY TWO LLC·Filed 2007·Granted Sep 21, 2010·0 cites·4 claims
- 0955US2008233185A1Fumaric Acid Derivatives as NF-kappaB InhibitorFUMAPHARM AG·Filed 2007·Application pending·0 cites
- 1054US8067533B2Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical compositionPETZELBAUER PETER·Filed 2007·Granted Nov 29, 2011·0 cites·6 claims
- 1153US2009286725A1Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical compositionFIBREX MEDICAL RES & DEV GMBH·Filed 2008·Application pending·0 cites
- 1250US2010099602A1Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injuryFIBREX MEDICAL RES & DEV GMBH·Filed 2009·Application pending·0 cites
- 1348US2009081192A1Methods of screening for compounds having anti-inflammatory activityFIBREX MEDICAL RES & DEV GMBH·Filed 2007·Application pending·0 cites
- 1446US2004054001A1Fumaric acid derivatives as nf-kappab inhibitorsFiled 2002·Application pending·0 cites
- 1545US7897574B2Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptomsIKARIA DEV SUBSIDIARY TWO LLC·Filed 2006·Granted Mar 1, 2011·0 cites·4 claims
- 1645US5602305AImmunodeficient animal model for studying T cell-mediated immuneUNIV YALE·Filed 1994·Granted Feb 11, 1997·16 cites·34 claims
- 1742US2009286740A1Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical compositionFIBREX MEDICAL RES & DEV GMBH·Filed 2008·Application pending·0 cites
- 1840US2010279924A1Peptides and peptide derivatives as well as pharmaceutical compositions containing the sameFIBREX MEDICAL RES & DEV GMBH·Filed 2010·Application pending·0 cites
- 1939US2008249006A1Pharmaceutical Preparation for the Treatment of ShockFIBREX MEDICAL RES & DEV GESMB·Filed 2005·Application pending·0 cites
- 2037US2010267615A1Methods for treatment and/or prevention of a disease associated with vascular leakFIBREX MEDICAL RES & DEV GMBH·Filed 2010·Application pending·0 cites
- 2136US9012403B2Peptides as active agents to stabilize biological barriersPETZELBAUER PETER·Filed 2011·Granted Apr 21, 2015·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →